These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1040 related items for PubMed ID: 15107719

  • 1. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM, Llorca PM, Despiegel N, Verpillat P.
    Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
    [Abstract] [Full Text] [Related]

  • 2. [Escitalopram for treatment of major depressive disorder in adults].
    Llorca PM, Brousse G, Schwan R.
    Encephale; 2005; 31(4 Pt 1):490-501. PubMed ID: 16389716
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 4. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]

  • 5. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP, Gourion D, Montagne A, Rostin M, Poirier MF.
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [Abstract] [Full Text] [Related]

  • 6. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J, Goa KL.
    CNS Drugs; 2003 Dec; 17(5):343-62. PubMed ID: 12665392
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH, Andersen HF, Lam RW.
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [Abstract] [Full Text] [Related]

  • 8. [Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram, in patients with major depressive disorder--the navigade switch study].
    Schmitt L, Arbus C, Tonnoir B.
    Encephale; 2006 Mar; 32(2 Pt 1):270-7. PubMed ID: 16910629
    [Abstract] [Full Text] [Related]

  • 9. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder.
    Lepola U, Wade A, Andersen HF.
    Int Clin Psychopharmacol; 2004 May; 19(3):149-55. PubMed ID: 15107657
    [Abstract] [Full Text] [Related]

  • 10. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ, Gergel I, Bose A.
    J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
    [Abstract] [Full Text] [Related]

  • 11. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
    Jacobsen PL, Mahableshwarkar AR, Chen Y, Chrones L, Clayton AH.
    J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
    [Abstract] [Full Text] [Related]

  • 12. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder.
    Baldwin DS, Cooper JA, Huusom AK, Hindmarch I.
    Int Clin Psychopharmacol; 2006 May; 21(3):159-69. PubMed ID: 16528138
    [Abstract] [Full Text] [Related]

  • 13. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
    Mao PX, Tang YL, Jiang F, Shu L, Gu X, Li M, Qian M, Ma C, Mitchell PB, Cai ZJ.
    Depress Anxiety; 2008 May; 25(1):46-54. PubMed ID: 17149753
    [Abstract] [Full Text] [Related]

  • 14. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
    Wade AG, Fernández JL, François C, Hansen K, Danchenko N, Despiegel N.
    Pharmacoeconomics; 2008 May; 26(11):969-81. PubMed ID: 18850765
    [Abstract] [Full Text] [Related]

  • 15. Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.
    Kornstein SG, Li D, Mao Y, Larsson S, Andersen HF, Papakostas GI.
    CNS Spectr; 2009 Jun; 14(6):326-33. PubMed ID: 19668123
    [Abstract] [Full Text] [Related]

  • 16. Escitalopram in the treatment of major depressive disorder: a meta-analysis.
    Kennedy SH, Andersen HF, Thase ME.
    Curr Med Res Opin; 2009 Jan; 25(1):161-75. PubMed ID: 19210149
    [Abstract] [Full Text] [Related]

  • 17. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.
    Mohamed S, Osatuke K, Aslam M, Kasckow J.
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):201-9. PubMed ID: 17062320
    [Abstract] [Full Text] [Related]

  • 18. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
    Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.
    J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
    [Abstract] [Full Text] [Related]

  • 19. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
    Bielski RJ, Ventura D, Chang CC.
    J Clin Psychiatry; 2004 Sep; 65(9):1190-6. PubMed ID: 15367045
    [Abstract] [Full Text] [Related]

  • 20. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.
    Clin Drug Investig; 2007 Sep; 27(7):481-92. PubMed ID: 17563128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.